| Guidelines for the diagnosis and management of multiple myeloma 2011. JM Bird, RG Owen, S D'Sa, JA Snowden, G Pratt, J Ashcroft, K Yong, ... British journal of haematology 154 (1), 2011 | 466 | 2011 |
| A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia MC Di Bernardo, D Crowther-Swanepoel, P Broderick, E Webb, G Sellick, ... Nature genetics 40 (10), 1204-1210, 2008 | 466 | 2008 |
| Immunodeficiency and immunotherapy in multiple myeloma G Pratt, O Goodyear, P Moss British journal of haematology 138 (5), 563-579, 2007 | 431 | 2007 |
| Transfusion‐transmitted hepatitis E in a ‘nonhyperendemic’country E Boxall, A Herborn, G Kochethu, G Pratt, D Adams, S Ijaz, CG Teo Transfusion medicine 16 (2), 79-83, 2006 | 396 | 2006 |
| The PARP inhibitor olaparib induces significant killing of ATM-deficient lymphoid tumor cells in vitro and in vivo VJ Weston, CE Oldreive, A Skowronska, DG Oscier, G Pratt, MJS Dyer, ... Blood, The Journal of the American Society of Hematology 116 (22), 4578-4587, 2010 | 353 | 2010 |
| Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group G Ryan, G Martinelli, M Kuper-Hommel, R Tsang, G Pruneri, K Yuen, ... Annals of Oncology 19 (2), 233-241, 2008 | 343 | 2008 |
| South Asian chronic lymphocytic leukaemia patients have more rapid disease progression in comparison to White patients C Gunawardana, B Austen, JE Powell, C Fegan, F Wandroo, A Jacobs, ... British journal of haematology 142 (4), 606-609, 2008 | 325 | 2008 |
| Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers C Pepper, TT Lin, G Pratt, S Hewamana, P Brennan, L Hiller, R Hills, ... Blood, The Journal of the American Society of Hematology 112 (9), 3807-3817, 2008 | 316 | 2008 |
| ATR inhibition induces synthetic lethality and overcomes chemoresistance in TP53- or ATM-defective chronic lymphocytic leukemia cells M Kwok, N Davies, A Agathanggelou, E Smith, C Oldreive, E Petermann, ... Blood, The Journal of the American Society of Hematology 127 (5), 582-595, 2016 | 305 | 2016 |
| Common variants at 2q37. 3, 8q24. 21, 15q21. 3 and 16q24. 1 influence chronic lymphocytic leukemia risk D Crowther-Swanepoel, P Broderick, MC Di Bernardo, SE Dobbins, ... Nature genetics 42 (2), 132-136, 2010 | 283 | 2010 |
| Guidelines for supportive care in multiple myeloma 2011 JA Snowden, SH Ahmedzai, J Ashcroft, S D’Sa, T Littlewood, E Low, ... British journal of haematology 154 (1), 76-103, 2011 | 266 | 2011 |
| MHC class I–associated phosphopeptides are the targets of memory-like immunity in leukemia M Cobbold, H De La Peña, A Norris, JM Polefrone, J Qian, AM English, ... Science translational medicine 5 (203), 203ra125-203ra125, 2013 | 259 | 2013 |
| A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia HE Speedy, MC Di Bernardo, GP Sava, MJS Dyer, A Holroyd, Y Wang, ... Nature genetics 46 (1), 56-60, 2014 | 234 | 2014 |
| The NF-κB subunit Rel A is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukemia and represents a promising therapeutic target S Hewamana, S Alghazal, TT Lin, M Clement, C Jenkins, ML Guzman, ... Blood, The Journal of the American Society of Hematology 111 (9), 4681-4689, 2008 | 233 | 2008 |
| Guidelines on the diagnosis and investigation of AL amyloidosis. JD Gillmore, A Wechalekar, J Bird, J Cavenagh, S Hawkins, M Kazmi, ... British journal of haematology 168 (2), 2015 | 224 | 2015 |
| Telomere dysfunction and fusion during the progression of chronic lymphocytic leukemia: evidence for a telomere crisis TT Lin, BT Letsolo, RE Jones, J Rowson, G Pratt, S Hewamana, C Fegan, ... Blood, The Journal of the American Society of Hematology 116 (11), 1899-1907, 2010 | 209 | 2010 |
| Arginine dependence of acute myeloid leukemia blast proliferation: a novel therapeutic target F Mussai, S Egan, J Higginbotham-Jones, T Perry, A Beggs, E Odintsova, ... Blood, The Journal of the American Society of Hematology 125 (15), 2386-2396, 2015 | 193 | 2015 |
| Common variation at 3q26. 2, 6p21. 33, 17p11. 2 and 22q13. 1 influences multiple myeloma risk D Chubb, N Weinhold, P Broderick, B Chen, DC Johnson, A Försti, ... Nature genetics 45 (10), 1221-1225, 2013 | 193 | 2013 |
| Genetics and prognostication in splenic marginal zone lymphoma: revelations from deep sequencing M Parry, MJJ Rose-Zerilli, V Ljungström, J Gibson, J Wang, R Walewska, ... Clinical Cancer Research 21 (18), 4174-4183, 2015 | 178 | 2015 |
| Results of a randomized trial of chlorambucil versus fludarabine for patients with untreated Waldenström macroglobulinemia, marginal zone lymphoma, or lymphoplasmacytic lymphoma V Leblond, S Johnson, S Chevret, A Copplestone, S Rule, O Tournilhac, ... Journal of clinical oncology 31 (3), 301-307, 2013 | 176 | 2013 |
